01/15/2025
3:17 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:18 PM | Swartz Robin (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
2:14 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/14/2025
2:17 PM | Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
3:29 PM | Swartz Robin (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
10:31 AM | Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
5:13 PM | EcoR1 Capital, LLC (Filed by)
Voyager Therapeutics (Subject)
| Form SC 13G/A | |
09/05/2024
7:06 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
3:10 PM | Jorgensen Nathan D. (Reporting)
Voyager Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/09/2024
3:11 PM | Jorgensen Nathan D. (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
6:06 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
06/07/2024
3:15 PM | GERAGHTY JAMES A (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:16 PM | Higgins Michael J (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:17 PM | Hyman Steven (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:19 PM | MACKEY CATHERINE J (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:20 PM | Onyia Jude (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:20 PM | PIERCE GLENN (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:05 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:01 PM | Voyager Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
3:00 PM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
4:20 PM | Voyager Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
4:20 PM | Voyager Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024
4:22 PM | Voyager Therapeutics (Filer)
| Form ARS | |
04/02/2024
2:24 PM | Sandrock Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
2:29 PM | Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024
4:24 PM | Ferguson Toby (Reporting)
Voyager Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/26/2024
4:27 PM | Ferguson Toby (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
6:03 AM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
3:00 PM | Voyager Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
3:30 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:32 PM | PFREUNDSCHUH PETER P. (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:34 PM | Sandrock Alfred (Reporting)
Voyager Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
2:13 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
2:16 PM | Swartz Robin (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
2:18 PM | PFREUNDSCHUH PETER P. (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
2:20 PM | Sandrock Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
2:11 PM | Carter Todd Alfred (Reporting)
Voyager Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
1:35 PM | ARMISTICE CAPITAL, LLC (Filed by)
Voyager Therapeutics (Subject)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Voyager Therapeutics (Subject)
| Form SC 13G | |
Free VYGR Stock Alerts